Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Gepharma Sverige AB
AB
Active
Org 5593305146
Tändkulevägen 33, 131 51
Nacka
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2021 · 4 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Gepharma Sverige AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
Revenue
39
112
235
324
Staff expenses
−0
−0
−0
−0
EBITDA
−1
52
156
255
Depreciation & amort.
—
—
—
—
EBIT
−1
52
156
255
Net financials
1
2
2
—
Profit before tax
0
69
193
205
Tax
−0
−14
−40
−42
Net profit
0
55
152
163
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
Total assets
122
140
274
325
Equity
85
85
180
188
Long-term debt
—
—
—
—
Short-term debt
37
55
80
88
Total debt
37
55
80
88
Financial ratios
5-year trend
EBITDA margin
−1,9 %
This company
15,8 %
Market median
This company
Market median
112% below market
2022
2025
Equity ratio
69,6 %
This company
38,2 %
Market median
This company
Market median
82% above market
2022
2025
Return on equity
0,1 %
This company
18,4 %
Market median
This company
Market median
99% below market
2022
2025
Net profit margin
0,2 %
This company
8,1 %
Market median
This company
Market median
98% below market
2022
2025
Asset turnover
0,32×
This company
1,12×
Market median
This company
Market median
71% below market
2022
2025
Debt / equity
0,44×
This company
0,62×
Market median
This company
Market median
29% below market
2022
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-08-13 – 2022-06-30
View
PDF
More on Gepharma Sverige AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
